Brooks Automation, Inc. (BRKS) Stock Analysis

Brooks Automation, Inc. (BRKS) Technology Profile & Competitive Position

Brooks Automation, Inc. delivers automation and cryogenic solutions, serving both the semiconductor and life sciences sectors. With a focus on wafer handling and sample management, the company provides critical tools and services to enhance efficiency and reliability in these technology-driven industries, operating in approximately 50 countries.

What Is the Investment Thesis for BRKS?

Brooks Automation operates in the growing semiconductor and life sciences industries, providing critical automation and cryogenic solutions. The company's diversified revenue streams from both segments offer stability, while its focus on innovation and strategic acquisitions positions it for long-term growth. However, a negative profit margin of -29.9% raises concerns about profitability. Key catalysts include increasing demand for automation in semiconductor manufacturing and expanding applications of cold storage in life sciences. Investors should monitor the company's ability to improve profitability and manage its debt effectively. The company's beta of 1.77 indicates higher volatility compared to the market.

Based on FMP financials and quantitative analysis

BRKS Key Highlights

Brooks Automation operates in two high-growth sectors: semiconductors and life sciences, providing diversification and growth opportunities.

• The company's gross margin of 44.6% indicates a strong ability to manage production costs and maintain profitability on core operations.
• Brooks Automation serves customers in approximately 50 countries, demonstrating a global presence and diversified revenue streams.
• The company's market capitalization of $7.82B reflects its significant position in the automation and cryogenic solutions market.
• Brooks Automation's solutions are critical for enhancing efficiency and reliability in semiconductor manufacturing and life sciences sample management.

Who Are BRKS's Competitors?

BRKS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BRKS's Key Strengths?

Strong market position in semiconductor and life sciences automation.

• Diversified revenue streams from equipment, consumables, and services.
• Global presence with customers in approximately 50 countries.
• Proprietary technology and expertise in automation and cryogenic solutions.

What Are BRKS's Weaknesses?

Negative profit margin of -29.9% indicates profitability challenges.

• High beta of 1.77 suggests higher volatility compared to the market.
• Dependence on cyclical industries like semiconductors.
• Potential for supply chain disruptions affecting component availability.

What Could Drive BRKS Stock Higher?

Increasing demand for automation in semiconductor manufacturing due to rising complexity and miniaturization.

• Growing adoption of automated cold storage solutions in the life sciences industry for sample management.
• Potential strategic acquisitions to expand product portfolio and market reach by Q4 2026.
• Expansion into emerging markets in Asia-Pacific and Latin America to drive revenue growth.
• Development of advanced cryogenic solutions for various industries, including healthcare and aerospace.

What Are the Key Risks for BRKS?

Negative return on equity (-10.7%) — the business is not currently generating profit on shareholder capital.

• Insider selling — insiders were net sellers of roughly $11.5M recently.
• Economic downturns affecting capital equipment spending in the semiconductor and life sciences industries.
• Intense competition from established and emerging players in automation and cryogenic solutions.
• Technological obsolescence requiring continuous innovation and investment in R&D.
• Supply chain disruptions affecting component availability and production costs.
• Negative profit margin of -29.9% indicating profitability challenges.

What Are the Growth Opportunities for BRKS?

• Expansion in Semiconductor Automation: The increasing complexity of semiconductor manufacturing processes requires advanced automation solutions. Brooks Automation can capitalize on this trend by developing more sophisticated wafer handling and contamination control systems. The global semiconductor equipment market is projected to reach $130 billion by 2028, offering significant growth potential for Brooks. By focusing on innovation in robotics and AI-driven automation, Brooks can enhance its market share and drive revenue growth.
• Growth in Life Sciences Sample Management: The demand for efficient and reliable sample management solutions in the life sciences industry is growing rapidly. Brooks Automation can expand its offerings in automated cold storage, sample tracking, and bio-processing solutions. The global biobanking market is expected to reach $65 billion by 2030, presenting a substantial opportunity for Brooks to increase its market presence and revenue through strategic partnerships and product development.
• Strategic Acquisitions: Brooks Automation has a history of strategic acquisitions to expand its product portfolio and market reach. The company can continue to pursue acquisitions of complementary businesses in automation and cryogenic solutions. By integrating new technologies and capabilities, Brooks can enhance its competitive position and drive synergistic growth. Identifying and acquiring companies with innovative solutions can provide a significant boost to Brooks' long-term growth prospects.
• Geographic Expansion: Brooks Automation serves customers in approximately 50 countries, but there is potential to further expand its geographic footprint. Focusing on emerging markets in Asia-Pacific and Latin America can provide new growth opportunities. By establishing local partnerships and distribution networks, Brooks can access new customers and increase its global market share. Tailoring products and services to meet the specific needs of these markets will be crucial for success.
• Development of Advanced Cryogenic Solutions: The demand for cryogenic solutions is increasing in various industries, including healthcare, aerospace, and energy. Brooks Automation can invest in the development of advanced cryogenic technologies for storage and transportation of biological samples, vaccines, and other temperature-sensitive materials. The global cryogenic market is projected to reach $28 billion by 2027, offering a significant opportunity for Brooks to establish itself as a leader in this field.

What Are BRKS's Competitive Advantages?

• Specialized Expertise: Brooks Automation has deep expertise in automation and cryogenic solutions for specific industries.
• Long-Standing Customer Relationships: The company has established long-term relationships with key customers in the semiconductor and life sciences sectors.
• Proprietary Technology: Brooks Automation owns proprietary technology in robotics, automation, and cryogenic systems.
• High Switching Costs: Customers face high switching costs due to the integration of Brooks' solutions into their critical processes.

What Does BRKS Do?

Founded in 1978 and headquartered in Chelmsford, Massachusetts, Brooks Automation, Inc. has evolved into a key player in automation and cryogenic solutions. Initially focused on serving the semiconductor industry, Brooks expanded its offerings to include life sciences with the Brooks Life Science Systems segment. The company's Semiconductor Solutions Group provides wafer automation and contamination control solutions, including atmospheric and vacuum robots, robotic modules, and automated cleaning and inspection systems. These products ensure precision handling and clean environments critical for semiconductor manufacturing. The Life Science Systems segment offers automated cold storage systems, consumables, and instruments for sample management, such as labeling, bar coding, and sealing equipment. Additionally, Brooks provides comprehensive sample management services, including on-site and off-site storage, cold chain logistics, and bio-processing solutions. Brooks Automation serves customers in approximately 50 countries, supporting both the semiconductor capital equipment and life sciences sample management markets.

What Products and Services Does BRKS Offer?

• Provides wafer automation solutions for semiconductor manufacturing.
• Offers contamination control systems to maintain clean wafer environments.
• Develops and manufactures atmospheric and vacuum robots.
• Provides automated cold storage systems for life sciences.
• Offers sample management services, including on-site and off-site storage.
• Supplies consumables like racks, tubes, and plates for sample management.
• Provides instruments for labeling, bar coding, and sealing tubes and plates.

How Does BRKS Make Money?

• Sells automation and cryogenic equipment to semiconductor and life sciences companies.
• Provides recurring revenue through consumables and sample management services.
• Offers maintenance, repair, and upgrade services for its equipment.
• Generates revenue through software solutions for sample intelligence and workflow management.

What Industry Does BRKS Operate In?

Brooks Automation operates within the semiconductor and life sciences industries, both experiencing significant growth. The semiconductor industry is driven by increasing demand for advanced chips in electronics, automotive, and AI. The life sciences sector is expanding due to advancements in drug discovery, personalized medicine, and the need for efficient sample management. Brooks competes with companies like SanDisk Corp. (SNDK), Altair Engineering Inc. (ALTR), and National Instruments Corporation (NATI), focusing on specialized automation and cryogenic solutions. The company's ability to innovate and adapt to evolving industry needs is crucial for maintaining its competitive edge.

Who Are BRKS's Key Customers?

• Semiconductor manufacturers requiring wafer automation solutions.
• Life sciences companies needing automated cold storage and sample management.
• Research institutions requiring cryogenic solutions for sample preservation.
• Pharmaceutical companies needing sample management for drug discovery and development.

Company Profile

Brooks Automation, Inc. operates in the Semiconductors industry within the Technology sector. It is headquartered in Chelmsford, US. The company is led by CEO Stephen Schwartz. BRKS has traded publicly since 1995.

Brooks Automation, Inc. Financial Trajectory

Brooks Automation, Inc. (BRKS) reported $161.2M in revenue for Q3 FY2026, reflecting 11.3% growth compared to the prior quarter. The company recorded net income of $2.5M, with diluted EPS of $54.23. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Technology. Across the four most recent quarters, BRKS averaged $11.84 in diluted EPS.

Return on equity for Brooks Automation, Inc. stands at -10.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 2.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.83 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -15.2%, the inverse of the P/E and a quick read on earnings relative to price.

Brooks Automation, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 14.09 places it in the safe zone, indicating low near-term bankruptcy risk.

Brooks Automation, Inc. has beaten Wall Street's EPS estimate in 4 of its last 4 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 10.3% above estimates on average.

The most recent 12 insider filings for Brooks Automation, Inc. break down as 11 sales and 1 purchases. On net that is roughly 97K shares disposed (about $11.5M), a signal worth weighing alongside the fundamentals.

BRKS Financials

BRKS Latest News

BRKS Technology Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources